Shibuya et al., Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family, Oncogene, 5(4):519-524, 1990. |
Borg et al., Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase, Oncogene, 10(5):973-984, Mar. 1995. |
Chamow, S.M., et al. "Immunoadhesins: principles and applications", TIBTECH, vol. 14, pp. 52-60 (1996). |
Aiello, L.P., et al. "Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins", Proc. Nat'l. Acad. Sci. USA, vol. 92 pp. 10457-10461 (Nov. 1995). |
Park, J.E., et al. "Placenta Growth Factor", The Journal of Biological Chemistry, vol. 269, No. 41, pp. 25646-25654 (Oct. 14, 1994). |
Cunningham, S.A., "Identification of the Extracellular Domains of Flt-1 That Mediate Ligand Interactions", Biochemical and Biophysical Research Communications, 231: pp. 596-599 (1997). |
Davis-Smyth, T., et al. "The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade", The EMBO Journal, vol. 15, No. 18, pp. 4919-4927 (1996). |
Ferrara et al., "The Vascular Endothelial Growth Factor Family of Polypeptides," Journal of Cellular Biochemistry, 47:211-218 (1991). |
Tischer et al., "The Human Gene for Vascular Endothelial Growth Factor," The Journal of Biological Chemistry, 266(18):11947-11954 (1991). |
Tischer et al., "Vascular Endothelial Growth Factor: A New Member of the Platelet-Derived Growth Factor Gene Family," Biochemical and Biophysical Research Communications, 165(3):1198-1206 (1989). |
Creighton, Proteins, WH Freeman and Company: New York, NY, pp. 223-227 (1984). |
Schulz et al., Principles of Protein Structure, Springer-Verlag: New York, NY, pp. 14-16 (1979). |
Rockwell et al., "In vitro Neutralization of Vascular Endothelial Growth Factor Activation of Flk-1 by a Monoclonal Antibody," Molecular and Cellular Differentiation, 3(1):91-109 (1995). |
Kendall and Thomas, "Inhibition of Vascular Endothelial Cell Growth Factor Activity by an Endogenously Encoded Soluble Receptor," Proc. Natl. Acad. Sci. USA, 90:10705-10709 (1993). |
Plowman et al., "Receptor Tyrosine Kinases as Targets for Drug Intervention," DN&P, 7(6):334-339 (1994). |
Heidaran et al., ".beta. PDGFR-IgG Chimera Demonstrates that Human .beta. PDGFR Ig-like Domains 1 to 3 are Sufficient for High Affinity PDGF BB Binding," FASEB J., 9:140-145 (1995). |
Cheon et al., "High-Affinity Binding Sites for Related Fibroblast Growth Factor Ligands Reside within Different Receptor Immunoglobulin-like Domains," Proc. Natl. Acad. Sci. USA, 91:989-993 (1994). |
Klein, Immunology: The Science of Self-Nonself Discrimination, Wiley-Interscience: New York, NY, pp. 160-161 and 190-191 (1982). |